Regeneron Pharmaceuticals Stock Pattern Recognition Takuri Dragonfly Doji with very long lower shadow

REGN Stock  USD 778.50  9.50  1.21%   
Regeneron Pharmaceuticals pattern recognition tool provides the execution environment for running the Takuri Dragonfly Doji with very long lower shadow recognition and other technical functions against Regeneron Pharmaceuticals. Regeneron Pharmaceuticals value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of pattern recognition indicators. As with most other technical indicators, the Takuri Dragonfly Doji with very long lower shadow recognition function is designed to identify and follow existing trends. Regeneron Pharmaceuticals momentum indicators are usually used to generate trading rules based on assumptions that Regeneron Pharmaceuticals trends in prices tend to continue for long periods.

Recognition
The output start index for this execution was ten with a total number of output elements of fifty-one. The function generated a total of one valid pattern recognition events for the selected time horizon. Takuri (The Dragonfly Doji pattern signals indecision among Regeneron Pharmaceuticals traders. The Dragonfly Doji with very long lower shadow pattern indicates that Regeneron Pharmaceuticals direction of the trend may be nearing a major turning point.)

Regeneron Pharmaceuticals Technical Analysis Modules

Most technical analysis of Regeneron Pharmaceuticals help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Regeneron from various momentum indicators to cycle indicators. When you analyze Regeneron charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Regeneron Pharmaceuticals Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Regeneron Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Regeneron Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Regeneron Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Regeneron Pharmaceuticals's daily price indicators and compare them against related drivers, such as pattern recognition and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Regeneron Pharmaceuticals's intrinsic value. In addition to deriving basic predictive indicators for Regeneron Pharmaceuticals, we also check how macroeconomic factors affect Regeneron Pharmaceuticals price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2021 2022 2023 2024 (projected)
Days Sales Outstanding137.09159.78157.7165.58
PTB Ratio3.563.413.615.22
Hype
Prediction
LowEstimatedHigh
776.74778.50780.26
Details
Intrinsic
Valuation
LowRealHigh
582.12583.88856.35
Details
Naive
Forecast
LowNextHigh
793.25795.01796.77
Details
25 Analysts
Consensus
LowTargetHigh
830.39912.521,013
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Regeneron Pharmaceuticals. Your research has to be compared to or analyzed against Regeneron Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Regeneron Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Regeneron Pharmaceuticals.

Regeneron Pharmaceuticals Implied Volatility

    
  0.15  
Regeneron Pharmaceuticals' implied volatility exposes the market's sentiment of Regeneron Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Regeneron Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Regeneron Pharmaceuticals stock will not fluctuate a lot when Regeneron Pharmaceuticals' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Regeneron Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Regeneron Pharmaceuticals' short interest history, or implied volatility extrapolated from Regeneron Pharmaceuticals options trading.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Banking Idea
Banking
Invested over 40 shares
Dividend Beast Idea
Dividend Beast
Invested over 50 shares
Power Assets Idea
Power Assets
Invested over 200 shares
Driverless Cars Idea
Driverless Cars
Invested over 50 shares
Business Services Idea
Business Services
Invested few shares
Momentum Idea
Momentum
Invested over 40 shares
Adviser Favorites Idea
Adviser Favorites
Invested few shares
Impulse Idea
Impulse
Invested few shares
Macroaxis Index Idea
Macroaxis Index
Invested few shares
FinTech Idea
FinTech
Invested few shares
Semiconductor Idea
Semiconductor
Invested few shares
Millennials Best Idea
Millennials Best
Invested few shares
When determining whether Regeneron Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Regeneron Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Regeneron Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Regeneron Pharmaceuticals Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Regeneron Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
To learn how to invest in Regeneron Stock, please use our How to Invest in Regeneron Pharmaceuticals guide.
You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Regeneron Pharmaceuticals. If investors know Regeneron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Regeneron Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.298
Earnings Share
40.46
Revenue Per Share
128.691
Quarterly Revenue Growth
0.106
Return On Assets
0.0741
The market value of Regeneron Pharmaceuticals is measured differently than its book value, which is the value of Regeneron that is recorded on the company's balance sheet. Investors also form their own opinion of Regeneron Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Regeneron Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Regeneron Pharmaceuticals' market value can be influenced by many factors that don't directly affect Regeneron Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Regeneron Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Regeneron Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Regeneron Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.